Amylyx Pharmaceuticals Funding: $172M Raised, Series C

Amylyx Pharmaceuticals is based in Cambridge, Massachusetts. It has raised $172M in total funding. Latest round: Series C.

Amylyx Pharmaceuticals funding overview

Amylyx Pharmaceuticals is based in Cambridge, Massachusetts. Amylyx Pharmaceuticals has raised $172M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in July 2021. The round record for Amylyx Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include Viking Global Investors, Belinda Termeer, 683 Capital Management, Bain Capital Life Sciences, Falcon Edge Capital, Marshall Wace and 7 others. 13 distinct backers are named across the disclosed rounds.

Amylyx Pharmaceuticals at a glance

Total raised
$172M
Latest round
Series C
Latest round date
July 2021
Headquarters
Cambridge, Massachusetts
Notable investors
Viking Global Investors, Belinda Termeer, 683 Capital Management, Bain Capital Life Sciences, Falcon Edge Capital, Marshall Wace, Morningside Ventures, Perceptive Advisors

Frequently asked about Amylyx Pharmaceuticals funding

How much has Amylyx Pharmaceuticals raised?
Amylyx Pharmaceuticals has raised $172M in total disclosed funding across the rounds on record.
Who has invested in Amylyx Pharmaceuticals?
Viking Global Investors, Belinda Termeer, 683 Capital Management, Bain Capital Life Sciences, Falcon Edge Capital, Marshall Wace are named among the investors backing Amylyx Pharmaceuticals.
What was the latest Amylyx Pharmaceuticals funding round?
The most recent disclosed round is a Series C, announced in July 2021.
Where is Amylyx Pharmaceuticals based?
Amylyx Pharmaceuticals is based in Cambridge, Massachusetts.
When did Amylyx Pharmaceuticals last raise?
The last disclosed Amylyx Pharmaceuticals round closed in July 2021 at Series C.

Every Amylyx Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.

Companies related to Amylyx Pharmaceuticals (36)

Browse related funding lists (8)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades